RxDoctor Payments Data

Ma Rosario de Jesus

Family Medicine · Seymour, INNPI 1508094665

Payments from drug & device makers

$444in general payments, 2019–2025

Across 33 payments — averaging $13.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$153
  • GSK$126
  • E.r. Squibb & Sons, L.L.C.$45
  • Vanda Pharmaceuticals Inc.$31
  • Novo Nordisk$30
  • Teva Pharmaceuticals USA, Inc.$26
  • plus $32 from 2 others

What the payments were for

  • Food & beverage$39990%
  • Education$4510%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$444 in reported general payments places this provider in the 45th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$204
Medicare patients
15
Services billed
20

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide66$68,466
EliquisApixaban11$15,625
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$9,707
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,976
TradjentaLinagliptin13$6,707
Arnuity ElliptaFluticasone Furoate13$3,565
Novolog FlexpenInsulin Aspart12$3,244
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$3,091
SymbicortBudesonide/Formoterol Fumarate14$2,959
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate18$1,064
Atorvastatin Calcium175$1,041
Gabapentin84$948
Albuterol Sulfate HfaAlbuterol Sulfate47$902
Ventolin HfaAlbuterol Sulfate16$867
Metoprolol Succinate52$603

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$30$68,46666 claims
GSKTrelegy Ellipta, Arnuity Ellipta$126$10,54124 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Seymour

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →